Usana Health Sciences Inc
USNA- Exchange
- NYSE
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0000896264
No open-market purchases or sales by Usana Health Sciences Inc insiders were filed in the last 90 days; 137 institutions reported holding it in 13F filings for Q2 2026, worth $243.0M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Usana Health Sciences Inc changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Of which not filed for Q4 2023 | Q4 2023 | Change |
|---|---|---|---|---|
| Holders | 161 | 1 | 167 | +7 |
| Shares | 10.2M | 4 | 10.4M | +182.7K (+1.8%) |
| Value | $602.0M | $0 | $558.1M | −$43.9M (−7.3%) |
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (23)
Institutions that held Usana Health Sciences Inc at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Tudor Investment Corp Et Al | 33,906 | $1.82M | 0.03% |
| First Trust Advisors LP | 33,354 | $1.79M | 0.00% |
| Squarepoint Ops LLC | 14,725 | $789.3K | 0.00% |
| Balyasny Asset Management LLC | 13,934 | $746.9K | 0.00% |
| Gsa Capital Partners LLP | 13,454 | $721.0K | 0.06% |
| Cornercap Investment Counsel Inc | 10,504 | $563.0K | 0.09% |
| Nebula Research & Development LLC | 10,111 | $542.0K | 0.16% |
| HRT Financial LP | 9,514 | $509.0K | 0.00% |
| Occudo Quantitative Strategies LP | 7,129 | $382.1K | 0.05% |
| Summit Global Investments | 5,733 | $307.0K | 0.02% |
| Trexquant Investment LP | 4,969 | $266.3K | 0.01% |
| Verition Fund Management LLC | 4,291 | $230.0K | 0.00% |
| Creative Planning | 4,219 | $226.1K | 0.00% |
| Susquehanna International Group, LLP | 3,843 | $206.0K | 0.00% |
| Quest Partners LLC | 1,230 | $65.9K | 0.01% |
| Lazard Asset Management LLC | 871 | $46.0K | 0.00% |
| WealthCollab, LLC | 469 | $25.1K | 0.02% |
| Huntington National Bank | 137 | $7.34K | 0.00% |
| ICA Group Wealth Management, LLC | 132 | $7.08K | 0.00% |
| Pineridge Advisors LLC | 20 | $1.07K | 0.00% |
| GAMMA Investing LLC | 12 | $562 | 0.00% |
| Assetmark, Inc | 3 | $161 | 0.00% |
| SJS Investment Consulting Inc. | 1 | $54 | 0.00% |
Sold out (16)
Institutions that held Usana Health Sciences Inc at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Los Angeles Capital Management LLC | 26,651 | $1.56M |
| O'Shaughnessy Asset Management, LLC | 10,269 | $601.9K |
| SG Americas Securities, LLC | 9,913 | $581.0K |
| Commonwealth of Pennsylvania Public School Empls Retrmt Sys | 7,485 | $438.7K |
| XTX Topco Ltd | 6,133 | $359.5K |
| Sequoia Financial Advisors, LLC | 4,803 | $281.5K |
| Ifrah Financial Services, Inc. | 3,504 | $205.4K |
| Cubist Systematic Strategies, LLC | 3,294 | $193.1K |
| Leonteq Securities AG | 1,151 | $67.5K |
| Altshuler Shaham Ltd | 379 | $22.2K |
| Point72 Middle East FZE | 313 | $18.4K |
| Point72 Asset Management, L.P. | 217 | $12.7K |
| Hillsdale Investment Management Inc. | 80 | $4.69K |
| Parkside Financial Bank & Trust | 25 | $1.47K |
| Baker Avenue Asset Management, LP | 8 | $469 |
| First Horizon Advisors, Inc. | 8 | $468 |
Not filed for Q4 2023 yet (1)
Institutions that held Usana Health Sciences Inc at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Steward Financial Group LLC | 4 | $0 |